Publications & Documents


  • 22-October-2008

    English

    Task Force on Biomedicine and Health Innovation

    In November 2007 the Working Party on Biotechnology established a new Task Force on Biomedicine and Health Innovation. The Task Force was asked to develop a Synthesis Report of the main policy messages that emerged from OECD work related to innovation and health.

  • 21-October-2008

    English, , 771kb

    Pharmaceutical Pricing and Reimbursement Policies in Germany

    This paper (Health Working Paper No. 39) describes pharmaceutical pricing and reimbursement policies in Germany, considering them in the broader environment in which they operate, and assesses their impact on the achievement of a number of policy goals.

  • 20-September-2007

    English

    Bio-based Economy

    The focus at the OECD on industrial biotechnology is to identify the potential contribution of biotechnology to sustainable growth and development, and identify and appraise policy options for supply and demand side interventions that can drive efficient transition towards bio-based economy.

  • 25-June-2007

    English

  • 14-June-2007

    English

    OECD Best Practice Guidelines for Biological Resource Centres

    This report presents the outcome of discussions held by the OECD member countries, together with a number of key partner countries, under the auspices of an expert Task Force established by the OECD Working Party on Biotechnology.

    Related Documents
  • 27-February-2007

    English

    Facing the Future: Korea's Family, Pension and Health Policy Challenges

    This summary study looks at existing Korean family, health and pension policies from an international perspective and considers them in view of the emerging policy challenges in Korea. It was presented at a policy forum on Low fertility and Ageing Society, in September 2006 in Seoul.

    Related Documents
  • 31-October-2006

    English

    Creation and Governance of Human Genetic Research Databases

    Summarises proceedings of a conference looking at examples of human genetic research databases, how they are established, how they are managed and governed, how they might be commercialised, and what the policy considerations might be.

    Related Documents
  • 22-May-2006

    English, , 849kb

    OECD Biotechnology Statistics 2006

    The 2006 edition OECD Biotechnology Statistics includes data for 23 OECD countries and two observer countries, plus China (Shanghai), and takes a major step forward in improving the comparability of biotechnology indicators among countries.

    Related Documents
  • 3-April-2006

    English

    Efficiency of Health Care Delivery: Co-ordination of Care

    Work in the area of efficiency is currently focusing on coordination-of-care policies as a tool for improving cost and quality outcomes. The study will cover the OECD countries and non-OECD countries that are members or prospective members of the European Union.

    Related Documents
  • 31-March-2006

    English

    Innovation in Pharmaceutical Biotechnology: Comparing National Innovation Systems at the Sectoral Level

    This publication examines the innovation system in pharmaceutical biotechnology in eight OECD countries. Based on rich evidence, it draws policy recommendations to foster innovation in biopharmaceuticals advocating an integrated policy approach.

    Related Documents
  • << < 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 > >>